Listed

Evotec SE

EVONasdaqCIK 1412558HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalentsEUR 306.4m, FY2024
Shareholders' equityEUR 952.5m, FY2024
Evotec SE, balance sheet, quarterly
Line itemUnitperiod not labelled2018-12-31period not labelled2019-12-31period not labelled2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31
Cash and equivalents$m109Cash and equivalents, period not labelled, at 2018-12-31EUR 109.1m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2022-04-26, accession 0001104659-22-049929.Report this figure277Cash and equivalents, period not labelled, at 2019-12-31EUR 277.0m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure423Cash and equivalents, period not labelled, at 2020-12-31EUR 422.6m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure699Cash and equivalents, FY2021, at 2021-12-31EUR 699.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure415Cash and equivalents, FY2022, at 2022-12-31EUR 415.2m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure511Cash and equivalents, FY2023, at 2023-12-31EUR 510.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure306Cash and equivalents, FY2024, at 2024-12-31EUR 306.4m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure
Current assets$mnot reportednot reported659Current assets, period not labelled, at 2020-12-31EUR 658.8m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2022-04-26, accession 0001104659-22-049929.Report this figure1,101Current assets, FY2021, at 2021-12-31EUR 1.10bn. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure1,074Current assets, FY2022, at 2022-12-31EUR 1.07bn. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure903Current assets, FY2023, at 2023-12-31EUR 903.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure682Current assets, FY2024, at 2024-12-31EUR 682.0m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure
Total assets$mnot reportednot reported1,462Total assets, period not labelled, at 2020-12-31EUR 1.46bn. XBRL concept ifrs-full:Assets. 20-F filed 2022-04-26, accession 0001104659-22-049929.Report this figure2,235Total assets, FY2021, at 2021-12-31EUR 2.24bn. XBRL concept ifrs-full:Assets. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure2,257Total assets, FY2022, at 2022-12-31EUR 2.26bn. XBRL concept ifrs-full:Assets. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure2,252Total assets, FY2023, at 2023-12-31EUR 2.25bn. XBRL concept ifrs-full:Assets. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure1,913Total assets, FY2024, at 2024-12-31EUR 1.91bn. XBRL concept ifrs-full:Assets. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure
Current liabilities$mnot reportednot reported208Current liabilities, period not labelled, at 2020-12-31EUR 208.5m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2022-04-26, accession 0001104659-22-049929.Report this figure325Current liabilities, FY2021, at 2021-12-31EUR 324.5m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure338Current liabilities, FY2022, at 2022-12-31EUR 337.7m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure465Current liabilities, FY2023, at 2023-12-31EUR 464.6m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure345Current liabilities, FY2024, at 2024-12-31EUR 344.6m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure
Shareholders' equity$m426Shareholders' equity, period not labelled, at 2018-12-31EUR 426.4m. XBRL concept ifrs-full:Equity. 20-F filed 2022-04-26, accession 0001104659-22-049929.Report this figure479Shareholders' equity, period not labelled, at 2019-12-31EUR 478.6m. XBRL concept ifrs-full:Equity. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure724Shareholders' equity, period not labelled, at 2020-12-31EUR 724.5m. XBRL concept ifrs-full:EquityAttributableToOwnersOfParent. 20-F filed 2022-04-26, accession 0001104659-22-049929.Report this figure1,378Shareholders' equity, FY2021, at 2021-12-31EUR 1.38bn. XBRL concept ifrs-full:EquityAttributableToOwnersOfParent. 20-F filed 2023-05-12, accession 0001104659-23-059900.Report this figure1,187Shareholders' equity, FY2022, at 2022-12-31EUR 1.19bn. XBRL concept ifrs-full:EquityAttributableToOwnersOfParent. 20-F filed 2024-08-14, accession 0001104659-24-089121.Report this figure1,120Shareholders' equity, FY2023, at 2023-12-31EUR 1.12bn. XBRL concept ifrs-full:EquityAttributableToOwnersOfParent. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure953Shareholders' equity, FY2024, at 2024-12-31EUR 952.5m. XBRL concept ifrs-full:EquityAttributableToOwnersOfParent. 20-F filed 2025-04-17, accession 0001104659-25-035638.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.